Hikma to replace Inmarsat in FTSE 100 index
LONDON, June 1 (Reuters) - Hikma Pharmaceuticals will be promoted to Britain's benchmark FTSE 100 equity index after a sharp rally in its shares since March, while satellite company Inmarsat will drop out of the FTSE. A spokesman for the London Stock Exchange announced the change via telep
Read more